Mesenchymal Stem Cells for Lumbar Degenerative Disc Disease

NCT03692221 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Stalled due to Covid

Conditions

Disc Degeneration

Interventions

DRUG: MSC Treatment group 1 (low dose)
DRUG: MSC Treatment group 2 (high dose)
OTHER: Healthy Control (no treatment)

Sponsor

University Hospitals Cleveland Medical Center